Invasive Mold Disease to High ICU and Ventilation Rates
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
A TB blood test identifies a bacterial marker to distinguish between active and latent tuberculosis infections.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
Children's Hospital Los Angeles joined a trial to investigate nula-cel, a gene-editing therapy designed to correct the sickle cell disease genetic mutation.
Adults with weakened immune systems, particularly transplant recipients, face significant risks of severe illness and death from respiratory syncytial virus (RSV).
A proof-of-concept study showed an experimental monoclonal antibody targeting ARDS inflammation increased ventilator-free days and reduced organ failure.
Zidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.